P

Inventor

LAM CHIA-YING KAO

US14 patents
⚠️ This page may combine multiple inventors who share the name “LAM CHIA-YING KAO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MACROGENICS INC

10 patents
US10647768B2May 12, 2020

Multi-chain polypeptide-containing tri-specific binding molecules

MACROGENICS INC19 citations92
US9908938B2Mar 6, 2018

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

MACROGENICS INC6 citations82
US11685781B2Jun 27, 2023

Variant CD3-binding domains and their use in combination therapies for the treatment of disease

MACROGENICS INC4 citations73
US10633443B2Apr 28, 2020

Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof

MACROGENICS INC3 citations73
US11459394B2Oct 4, 2022

Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

MACROGENICS INC4 citations72
US11820818B2Nov 21, 2023

Multi-chain polypeptide-containing tri-specific binding molecules

MACROGENICS INC1 citations71
US11421031B2Aug 23, 2022

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

MACROGENICS INC2 citations71
US11942149B2Mar 26, 2024

Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof

MACROGENICS INC1 citations62
US11639386B2May 2, 2023

Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof

MACROGENICS INC1 citations62
US10730947B2Aug 4, 2020

Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof

MACROGENICS INC1 citations61

UNIV DUKE

2 patents

NGM BIOPHARMACEUTICALS INC

2 patents